These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 2683091)
1. Descriptive analysis of the European Fraxiparin Study. Biegholdt M Semin Thromb Hemost; 1989 Oct; 15(4):409-13. PubMed ID: 2683091 [TBL] [Abstract][Full Text] [Related]
2. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group. Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187 [TBL] [Abstract][Full Text] [Related]
3. Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone. Veth G; Meuwissen OJ; van Houwelingen HC; Sixma JJ Thromb Haemost; 1985 Oct; 54(3):570-3. PubMed ID: 4089792 [TBL] [Abstract][Full Text] [Related]
4. [The postoperative prevention of deep venous thrombosis and pulmonary embolism with defibrotide versus heparin-calcium: a randomized clinical multicenter study of 1296 patients undergoing major abdominal surgery]. Di Somma C; Canepa G; Gipponi M; Frascio M Ann Ital Chir; 1992; 63(1):83-8. PubMed ID: 1605451 [TBL] [Abstract][Full Text] [Related]
5. A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis. Onarheim H; Lund T; Heimdal A; Arnesjø B Acta Chir Scand; 1986 Oct; 152():593-6. PubMed ID: 3544625 [TBL] [Abstract][Full Text] [Related]
6. [Prophylaxis of postoperative deep vein thromboses by means of weak doses of subcutaneous heparin (author's transl)]. Kraytman M; Kutnowski M; Ansay J; Fastrez R Acta Chir Belg; 1976 Sep; 75(5):519-29. PubMed ID: 1015181 [TBL] [Abstract][Full Text] [Related]
7. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group. Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557 [TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
9. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients. Urlep-Salinović V; Jelatancev B; Gorisek B Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365 [TBL] [Abstract][Full Text] [Related]
10. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Haas S; Flosbach CW Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721 [TBL] [Abstract][Full Text] [Related]
11. [Defibrotide and heparin in the prevention of deep venous thromboses. A controlled study]. Villani LG; Dalla Valle R; Rubini P Minerva Chir; 1990 Aug; 45(15-16):1029-33. PubMed ID: 2280855 [TBL] [Abstract][Full Text] [Related]
12. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty]. Guan ZP; Lü HS; Chen YZ; Song YN; Qin XL; Jiang J Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1317-20. PubMed ID: 16271243 [TBL] [Abstract][Full Text] [Related]
13. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis. DiSerio FJ; Sasahara AA Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790 [TBL] [Abstract][Full Text] [Related]
14. Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin. Welzel D; Wolf H; Koppenhagen K Arzneimittelforschung; 1988 Jan; 38(1):120-3. PubMed ID: 2835055 [TBL] [Abstract][Full Text] [Related]
15. Thromboprophylactic effect of low molecular weight heparin started in the evening before elective general abdominal surgery: a comparison with low-dose heparin. Bergqvist D; Burmark US; Frisell J; Guilbaud O; Hallböök T; Horn A; Lindhagen A; Ljungner H; Ljungström KG; Mätzsch T Semin Thromb Hemost; 1990 Oct; 16 Suppl():19-24. PubMed ID: 1962900 [TBL] [Abstract][Full Text] [Related]
16. Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? Carr MH; Towers CV; Eastenson AR; Pircon RA; Iriye BK; Adashek JA J Matern Fetal Med; 1997; 6(5):264-7. PubMed ID: 9360183 [TBL] [Abstract][Full Text] [Related]
17. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice]. Heidenreich C; Hohmann V; Bramlage P Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593 [TBL] [Abstract][Full Text] [Related]
18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Koppenhagen K; Adolf J; Matthes M; Tröster E; Roder JD; Hass S; Fritsche HM; Wolf H Thromb Haemost; 1992 Jun; 67(6):627-30. PubMed ID: 1324534 [TBL] [Abstract][Full Text] [Related]
20. Is DVT prophylaxis overemphasized? A randomized prospective study. Kosir MA; Kozol RA; Perales A; McGee K; Beleski K; Lange P; Dahn M J Surg Res; 1996 Feb; 60(2):289-92. PubMed ID: 8598656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]